1. Home
  2. MLYS vs CPRI Comparison

MLYS vs CPRI Comparison

Compare MLYS & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$29.26

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Capri Holdings Limited

CPRI

Capri Holdings Limited

HOLD

Current Price

$18.21

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
CPRI
Founded
2019
1981
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
MLYS
CPRI
Price
$29.26
$18.21
Analyst Decision
Strong Buy
Buy
Analyst Count
7
13
Target Price
$48.67
$26.62
AVG Volume (30 Days)
1.7M
2.6M
Earning Date
05-06-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
37.43
111.40
EPS
N/A
1.14
Revenue
N/A
$3,474,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.81
P/E Ratio
N/A
$15.70
Revenue Growth
N/A
N/A
52 Week Low
$12.59
$16.72
52 Week High
$47.65
$28.27

Technical Indicators

Market Signals
Indicator
MLYS
CPRI
Relative Strength Index (RSI) 60.61 43.03
Support Level $25.88 $16.82
Resistance Level $31.29 $22.08
Average True Range (ATR) 1.49 0.80
MACD 0.58 -0.16
Stochastic Oscillator 70.30 21.41

Price Performance

Historical Comparison
MLYS
CPRI

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About CPRI Capri Holdings Limited

Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.

Share on Social Networks: